SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001213900-22-072371
Filing Date
2022-11-14
Accepted
2022-11-14 17:01:20
Documents
51
Period of Report
2022-09-30

Document Format Files

Seq Description Document Type Size
1 QUARTERLY REPORT f10q0922_actiniumpharma.htm   iXBRL 10-Q 798117
2 CERTIFICATION f10q0922ex31-1_actiniumphar.htm EX-31.1 10947
3 CERTIFICATION f10q0922ex31-2_actiniumphar.htm EX-31.2 11444
4 CERTIFICATION f10q0922ex32-1_actiniumphar.htm EX-32.1 4980
5 CERTIFICATION f10q0922ex32-2_actiniumphar.htm EX-32.2 5483
11 GRAPHIC image_003.jpg GRAPHIC 49842
12 GRAPHIC image_004.jpg GRAPHIC 31168
  Complete submission text file 0001213900-22-072371.txt   3650021

Data Files

Seq Description Document Type Size
6 XBRL SCHEMA FILE atnm-20220930.xsd EX-101.SCH 40003
7 XBRL CALCULATION FILE atnm-20220930_cal.xml EX-101.CAL 22531
8 XBRL DEFINITION FILE atnm-20220930_def.xml EX-101.DEF 153524
9 XBRL LABEL FILE atnm-20220930_lab.xml EX-101.LAB 353350
10 XBRL PRESENTATION FILE atnm-20220930_pre.xml EX-101.PRE 166069
45 EXTRACTED XBRL INSTANCE DOCUMENT f10q0922_actiniumpharma_htm.xml XML 297450
Mailing Address 275 MADISON AVENUE, 7TH FLOOR NEW YORK NY 10016
Business Address 275 MADISON AVENUE, 7TH FLOOR NEW YORK NY 10016 646-677-3875
Actinium Pharmaceuticals, Inc. (Filer) CIK: 0001388320 (see all company filings)

IRS No.: 880378336 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36374 | Film No.: 221387244
SIC: 2834 Pharmaceutical Preparations